Skip to content

Clinical trials

Phase 2 Amyotrophic Lateral Sclerosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Phase 2 Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20161
20171
20192
20202
20215
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Terminated3
Withdrawn2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clene Nanomedicine2
Implicit Bioscience2
Apellis Pharmaceuticals, Inc.1
Collaborative Medicinal Development Pty Limited1
Cytokinetics1
GlaxoSmithKline1
Macquarie University, Australia1
Neuroscience Trials Australia1
Novartis Pharmaceuticals1
PTC Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis17
Motor Neuron Disease4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.